Rankings
Publications
Search Publications
Cited-by Search
Sources
Publishers
Scholars
Scholars
Top Cited Scholars
Organizations
About
Scilit
About Us
Advisory Board
Data Sources
Career
Support / Contact
User Guide
Publisher User
Search Function
Rankings Function
API Resource
Scilit Knowledge
Metrics
Scilit Recognitions
Publications Classification
Media
News
Blog
Login
Register
Home
Publications
1238P AUTOMAN: A phase Ib/IIa study of osimertinib combined with anlotinib in EGFRm, treatment-naive advanced NSCLC patients
Home
Publications
1238P AUTOMAN: A phase Ib/IIa study of osimertinib combined with anlotinib in EGFRm, treatment-naive advanced NSCLC patients
1238P AUTOMAN: A phase Ib/IIa study of osimertinib combined with anlotinib in EGFRm, treatment-naive advanced NSCLC patients
Authors:
BH
B. Han
B. Han
BY
B. Yan
B. Yan
AG
A. Gu
A. Gu
TC
T. Chu
T. Chu
WZ
W. Zhang
W. Zhang
HW
H. Wang
H. Wang
HZ
H. Zhong
H. Zhong
C. Shi
C. Shi
XZ
X. Zhang
X. Zhang
Article Alert
Citation Alert
Add to Library
Cite
Download
Share
Download
Publisher website
Google Scholar
1 September 2021
journal article
abstracts
Published by
Elsevier
in
Annals of Oncology
Vol. 32
,
S977
DOI:
10.1016/j.annonc.2021.08.1843
Abstract
No abstract available
Keywords
OSIMERTINIB
Cited
Cited by 2 articles
Scroll to top